| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1988 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1989 | 2015 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 1996 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | |||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1991 | 2012 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.905 | 42 | 3 | 1993 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1993 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2015 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2000 | ||||||||
|
fibroblast growth factor 1 | 0.507 | 0.846 | 0.44 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 1996 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2001 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1995 | 1995 | ||||||||
|
serpin family A member 6 | 0.606 | 0.731 | 8.3E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2019 | ||||||||
|
NK2 homeobox 1 | 0.457 | 0.808 | 0.36 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2016 | ||||||||
|
CEA cell adhesion molecule 3 | 0.494 | 0.731 | 1.1E-09 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2013 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2013 | ||||||||
|
CEA cell adhesion molecule 7 | 0.494 | 0.769 | 1.3E-07 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2013 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2013 | ||||||||
|
fibroblast growth factor 13 | 0.514 | 0.808 | 0.89 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2007 | ||||||||
|
transcription termination factor 1 | 0.537 | 0.500 | 6.2E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
neurotensin | 0.517 | 0.769 | 3.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
glycogen synthase kinase 3 alpha | 0.644 | 0.538 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
adhesion G protein-coupled receptor E2 | 0.581 | 0.615 | 2.8E-28 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1997 | 2019 |